Notch1 Is a 5-Fluorouracil Resistant and Poor Survival Marker in Human Esophagus Squamous Cell Carcinomas

• Jian Liu ,

  Contributed equally to this work with: Jian Liu, Huijie Fan

  Affiliations Department of Pathology, The First Teaching Hospital of Zhengzhou University, Basic Medical College, Zhengzhou University, Zhengzhou, Henan Province, China, Department of Pathology, the Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Oslo, Norway

  ⨯
• Huijie Fan ,

  Contributed equally to this work with: Jian Liu, Huijie Fan

  Affiliation Department of Oncology, The First Teaching Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

  ⨯
• Yuanyuan Ma,

  Affiliations Department of Pathology, the Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Oslo, Norway, Department of Pathology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Dongming Liang,

  Affiliation Department of Pathology, the Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Oslo, Norway

  ⨯
• Ruixia Huang,

  Affiliations Department of Pathology, the Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Oslo, Norway, Department of Pathology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Junsheng Wang,

  Affiliation Department of Oncology, Anyang Tumor Hospital, Anyang, Henan Province, China

  ⨯
• Fuyou Zhou,

  Affiliation Department of Surgery, Anyang Tumor Hospital, Anyang, Henan Province, China

  ⨯
• Quancheng Kan,

  Affiliation Department of Pharmacology, The First Teaching Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

  ⨯
• Liang Ming,

  Affiliation Department of Medical Laboratory, The First Teaching Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

  ⨯
• Huixiang Li,

  Affiliation Department of Pathology, The First Teaching Hospital of Zhengzhou University, Basic Medical College, Zhengzhou University, Zhengzhou, Henan Province, China

  ⨯
• Karl-Erik Giercksky,

  Affiliation Department of Surgery, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Oslo, Norway

  ⨯
• Jahn Martin Nesland,

  Affiliations Department of Pathology, the Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Oslo, Norway, Department of Pathology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Zhenhe Suo

  * E-mail: zhenhesuo@yahoo.com.cn

  Affiliations Department of Pathology, the Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Oslo, Norway, Department of Oncology, The First Teaching Hospital of Zhengzhou University, Zhengzhou, Henan Province, China, Department of Pathology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯